Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
I••••••••• P•••••••
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 11 of 11 distinct vehicles are sworn Private Equity Funds; 11 reported gross assets on a filing in 2022 or later
- Size band
- Lower middle marketdefined by: proxy: $0.21bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 11 of 11 distinct vehicles are sworn Private Equity Funds; 11 reported gross assets on a filing in 2022 or later
- Adviser type
- registered investment adviser
- Form ADV filings
- Jul 17, 2018 to Mar 27, 2024
- RAUM
- $213Mregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 11
- PE fund GAV, latest filing
- $210Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $210Mevery private fund type, latest filing
- 2024 PE fund GAV
- $210Msum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-27, latest gav Private Equity Fund $210M, latest counts Private Equity Fund 11, lifetime distinct Private Equity Fund 11
- Employees
- 6
- Headquarters
- New York, NY
- Office address
- 570 LEXINGTON AVENUE, 22ND FLOOR, New York, NY, 10022
- Business phone
- 212-652-3550
- Sectors
- technology
- Geography
- United States, Europe
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- control
- Thesis
- We partner with exceptional management teams to build innovative, differentiated and high-growth medical technology companies.
- roles
- unknown 12, platform 1
- period
- to 2025-06-30, from 2025-06-30, undated holdings 12, dated observations 2
- window
- last 2025-06-30, first 2025-06-30
- control
- control 1, unknown 12
- companies
- 13
- geography
- count 2, share 0.154, value CA, count 1, share 0.077, value UT
- investments
- 13
- seller kinds
- transactions
- 1
- cadence by year
- 2025 other deals 1
- platform add on
- add ons 0, platforms 1, add ons per platform unknown
- sector known for
- 4
- disclosed value usd
- n 0
- sector distribution
- count 2, share 0.154, value healthcare services, examples Nexa Orthopedics, Blue Belt Technologies, count 1, share 0.077, value software, examples ImmersiveTouch, count 1, share 0.077, value life sciences, examples Biohorizons
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 2, share 0.154, value outpatient specialty clinics, examples Nexa Orthopedics, Blue Belt Technologies, count 1, share 0.077, value software, examples ImmersiveTouch, count 1, share 0.077, value medical devices, examples Biohorizons
13 companies on the graph (1 transactions); most in healthcare services (2); 1 platforms and 0 add-ons; observed 2025 to 2025
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| I•• C•••••••• I•••• L• ADV: Private Equity Fund | Co-investment vehicle | 2024 first reported on Form ADV | $3.0M as of Mar 27, 2024 | no Form D | Unknown | |
| I•• C•••••••• I•••• L• ADV: Private Equity Fund | Co-investment vehicle | 2024 first reported on Form ADV | $2.3M as of Mar 27, 2024 | no Form D | Unknown | |
| I•• C•••••••• V• L• ADV: Private Equity Fund | Co-investment vehicle | 2023 first reported on Form ADV | $7.4M as of Mar 27, 2024 | no Form D | Early deployment | |
| I•• C•••••••• V•• L• ADV: Private Equity Fund | Co-investment vehicle | 2023 first reported on Form ADV | $6.2M as of Mar 27, 2024 | no Form D | Early deployment | |
| I•• C•••••••• I••• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $18.0M as of Mar 27, 2024 | no Form D | Early deployment | |
| I•• C•••••••• I•• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $16.8M as of Mar 27, 2024 | no Form D | Early deployment | |
| I•• C•••••••• I•••• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $5.8M as of Mar 27, 2024 | no Form D | Early deployment | |
| I•• C•••••••• I••• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $4.0M as of Mar 27, 2024 | no Form D | Unknown | |
| I•• C•••••••• I• L• ADV: Private Equity Fund | Co-investment vehicle | 2020 first reported on Form ADV | $24.7M as of Mar 27, 2024 | no Form D | Mature | |
| I•• C•••••••• I•• L• ADV: Private Equity Fund | Co-investment vehicle | 2020 first reported on Form ADV | $9.7M as of Mar 27, 2024 | no Form D | Successor fundraising | |
| I••••••••• P••••••• F•••• L• ADV: Private Equity Fund | buyout or unlabelled | unknown | $112M as of Mar 27, 2024 | no Form D | Unknown |
- J••• C• M•••••••• · Partner & Founder · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M••••••• B•••••••• I•• · Managing Partner & Founder · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- R•••••• B• E••••• · Senior Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- N••• P•••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- T•••••• C••••••• · Senior Manager - Investor Relations & Marketing · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A•••••• G••••• · Member And Board Of Managers Member · since Dec 1, 2017 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- J••• C• M•••••••• · Member And Board Of Managers Member · since Dec 1, 2017 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- M••••••• B•••••••• I•• · Member And Board Of Managers Member · since Dec 1, 2016 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- N•••••• S••••••• · Executive Assistant · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A•••••• G••••• · MD · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- T••• C••••••• · MD · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Jun 30, 2025 | Majority investment | I••••••••• | Sponsor (confirmed) | prnewswire.com |
- M•••• C•••• A••••• L••• 11 shared · very strong · last Jan 1, 2024
- N•••• S•• S••••••••• L••• 11 shared · very strong · last Jan 1, 2024
- S••••••••• C•••••• A•••••••• L•• 1 shared · one time · last Jan 1, 2022
- A•••••••• A••••••• S• 1 shared · one time · last Jan 1, 2018
- S••••• L••• P•••••••• L•• 1 shared · one time · last Jan 1, 2018
- R••••••••• S••••••••• I••• 1 shared · one time · last Jan 1, 2020
- B•••••• C•••••• 1 shared · one time · last Jan 1, 2018
- T•••••• C•••••• P•••••••• L•• 1 shared · one time · last Jan 1, 2018
- N••••• I••••••••• L••• 1 shared · one time · last Jan 1, 2018
- R••• • Z•••• L•• a•• G•••••••• T•••••• L•• 1 shared · one time · last Jun 30, 2025
- Sep 17, 2026Done Deal: Baxter Acquiring HillRom for $12.4 Billion
- Sep 17, 2026Lisa Garrett Joins C•••••• M••••••••• Board of Directors
- Sep 17, 2026M•••••• M•••••• Secures $20 Million Investment Led By I••••••••• P•••••••
- Sep 17, 2026Cassling Partners with R••••••••• M•••••• to Help Protect Interventional Teams from Scatter Radiation
- Sep 17, 2026M•••••• M•••••• Completes First Close of Series B2 Financing Round
- Sep 17, 2026K••••• Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy
- Sep 17, 2026M•••••• M•••••• Completes Enrollment in EASE Trial of Ellora™ Obstetrical System Used in First-Time Mothers
- Aug 5, 2026I••••••••• P•••••••: Private Equity Funds on Form ADV 11 (2024 extract) -> 16 (roster 2026-09-01)
- Jun 30, 2025HealthpointCapital Acquires I•••••••••, Inc., a Leading Extended Reality Surgical Platform
- Jul 17, 2018I••••••••• P••••••• first filed Form ADV in the extract (ERA)
I••••••••• P••••••• is the same institution as 3 records in Venture Capital, Independent Sponsors and RIA and Wealth.
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…